Skip to main content
. Author manuscript; available in PMC: 2009 Mar 1.
Published in final edited form as: Neuropharmacology. 2007 Nov 17;54(3):577–587. doi: 10.1016/j.neuropharm.2007.11.002

Figure 5. Administration of the AMPA receptor inhibitor, NBQX, attenuates the effects of lithium in the mouse FST and TST.

Figure 5

Mice were treated with lithium or control chow for 1.5 days. NBQX or vehicle was administered 30 minutes prior to behavioral testing. NBQX, at a dose of 10 mg/kg, attenuated the antidepressant-like effects of lithium in the FST (a) and TST (b). N = 6 to 8 mice per group. * p <0.05; ** p < 0.01, posthoc test versus all other groups